Christine Marie Utter, SVP, FINANCE & CAO at PTC THERAPEUTICS, INC. (PTCT), sold 52,816 shares at $44.71 ($2.4M) on 2023-03-27, disclosed to the SEC on 2023-03-29.
Scheduled sale ($2.4M) by SVP, FINANCE & CAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.71 | 4,475 | $200K | 8.4% |
| 2 | $44.71 | 4,475 | $200K | 8.4% |
| 3 | $44.72 | 7,949 | $355K | 14.9% |
| 4 | $44.72 | 7,949 | $355K | 14.9% |
| 5 | $45.38 | 4,954 | $225K | 9.4% |
| 6 | $45.38 | 4,954 |
| $225K |
| 9.4% |
| 7 | $45.42 | 8,780 | $399K | 16.7% |
| 8 | $45.42 | 8,780 | $399K | 16.7% |
| 9 | $46.01 | 200 | $9K | 0.4% |
| 10 | $46.01 | 300 | $14K | 0.6% |
| Total | $45.09 avg | 52,816 | $2.4M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $79K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $202K | — | Filing → |
| PTCT | SELL | 2025-02-21 | $88K | — | Filing → |